Medicare Enrolled
Dr. Samuel Lee, M.D.
Urology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Samuel Lee is an urology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 3,967 Medicare services across 2,328 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $8,850 from 36 pharmaceutical and/or device companies across 271 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in CA
$8,850 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,967
Medicare services
Top 21% in CA for urology physician
2,328
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~209 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,034 | $76 | $140 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
880 | $4 | $6 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
621 | $10 | $30 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
254 | $10 | $55 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
152 | $15 | $40 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 149 | $136 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
138 | $109 | $160 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
120 | $138 | $225 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
118 | $292 | $425 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
104 | $91 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
99 | $66 | $230 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
55 | $30 | $100 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
46 | $48 | $94 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
44 | $55 | $135 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
35 | $120 | $251 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $109 | $180 |
| Tumor antigen immunologic analysis A laboratory test that uses immunologic methods to detect the presence of tumor antigens in a sample. The results are reported as qualitative or semiquantitative findings. |
29 | $25 | $29 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $75 | $120 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $145 | $250 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
18 | $110 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,850
Total received (2018-2024)
Avg $1,264/year across 7 years
Top 22% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
271
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,154 (92.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$696 (7.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,028
2023
$1,290
2022
$1,891
2021
$798
2020
$1,033
2019
$791
2018
$2,018
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$327
Sumitomo Pharma America, Inc.
$199
PFIZER INC.
$141
Teleflex LLC
$110
Olympus America Inc.
$91
ABBVIE INC.
$59
VERTEX PHARMACEUTICALS INCORPORATED
$24
Boston Scientific Corporation
$24
UROGEN PHARMA, INC.
$20
ACCORD HEALTHCARE, INC.
$18
PROCEPT BioRobotics Corporation
$14
Top 3 companies account for 65.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$1,579
PFIZER INC.
$1,557
Astellas Pharma US Inc
$1,405
NeoTract Inc.
$980
Sumitomo Pharma America, Inc.
$421
Teleflex LLC
$329
Coloplast Corp
$276
Medtronic USA, Inc.
$250
Avadel Specialty Pharmaceuticals, LLC
$220
Boston Scientific Corporation
$212
ABBVIE INC.
$181
UROVANT SCIENCES INC
$166
Celltrion, Inc.
$145
Janssen Pharmaceuticals, Inc
$121
Olympus America Inc.
$114
COLOPLAST CORP
$92
TOLMAR Pharmaceuticals, Inc.
$88
Dendreon Pharmaceuticals LLC
$83
Tolmar, Inc.
$78
AbbVie, Inc.
$74
Janssen Biotech, Inc.
$72
ACCORD HEALTHCARE, INC.
$62
NxThera, Inc.
$47
C. R. Bard, Inc. & Subsidiaries
$42
Roche Diagnostics Corporation
$40
AbbVie Inc.
$25
Myovant Sciences Inc.
$24
VERTEX PHARMACEUTICALS INCORPORATED
$24
UroGen Pharma, Inc.
$23
Allergan Inc.
$23
UROGEN PHARMA, INC.
$20
Integra LifeSciences Corporation
$18
KARL STORZ Endoscopy-America
$18
Neurocrine Biosciences, Inc.
$17
PROCEPT BioRobotics Corporation
$14
Cumberland Pharmaceuticals, Inc.
$12
Top 3 companies account for 51.3% of all-time payments
Associated products mentioned in payments ›
0.30MM · 24/26 FR. · AMS · AQUABEAM SYSTEM · AXIS · Altis · Androgel · BIPOLAR · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · CUTTING LOOP · Camera Heads · ELIGARD · ERLEADA · Erleada · GEMTESA · INGREZZA · INTERSTIM · Integra · JELMYTO · LUPRON DEPOT · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · ORGOVYX · Obtryx System - Curved · PROVENGE · RS Harmony Test Related Products · Rezum · Rezum Generator · SOLYX · SPEEDICATH · Supris · TOVIAZ · Totect · UROLIFT · UroLift · UroLift System · VESICARE · XARELTO · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
408
Per 100K population
4.1
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.9 mi
0.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 21% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lee performed 1,034 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $8,850 from 36 companies across 271 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other urology physicians in Los Angeles?
Dr. Lee's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Los Angeles
Browse urology physicians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology